These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20932268)

  • 21. Homocysteine and Non-Cardiac Vascular Disease.
    Katsiki N; Perez-Martinez P; Mikhailidis DP
    Curr Pharm Des; 2017; 23(22):3224-3232. PubMed ID: 28317478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction.
    Agoston-Coldea L; Mocan T; Gatfosse M; Lupu S; Dumitrascu DL
    Cardiol J; 2011; 18(1):55-62. PubMed ID: 21305486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Homocysteine--a routine biochemical parameter in cardiovascular diseases?].
    Gábor D; Hrnciar J; Hricová I; Zacharová M
    Vnitr Lek; 1999 Jan; 45(1):40-5. PubMed ID: 10422525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine and risk of cardiovascular disease.
    Andreotti F; Burzotta F; Manzoli A; Robinson K
    J Thromb Thrombolysis; 2000 Jan; 9(1):13-21. PubMed ID: 10590184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Homocysteine as health risk: who is affected?].
    Kinderkrankenschwester; 2009 Aug; 28(8):327. PubMed ID: 19728469
    [No Abstract]   [Full Text] [Related]  

  • 26. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
    Clarke R; Stansbie D
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):624-32. PubMed ID: 11732645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review.
    Herrmann W; Herrmann M; Joseph J; Tyagi SC
    Clin Chem Lab Med; 2007; 45(12):1633-44. PubMed ID: 18067448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular pathogenesis in hyperhomocysteinemia.
    Huang T; Yuan G; Zhang Z; Zou Z; Li D
    Asia Pac J Clin Nutr; 2008; 17(1):8-16. PubMed ID: 18364320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperhomocysteinemia--a predictor of inflammatory changes in the liver].
    Zviagintseva TD; Hlushchenko SV
    Lik Sprava; 2014 Nov; (11):154-5. PubMed ID: 25528857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective homocysteine-lowering gene transfer attenuates pressure overload-induced cardiomyopathy via reduced oxidative stress.
    Muthuramu I; Singh N; Amin R; Nefyodova E; Debasse M; Van Horenbeeck I; Jacobs F; De Geest B
    J Mol Med (Berl); 2015 Jun; 93(6):609-18. PubMed ID: 25860230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of homocysteine and its relationship with cardiovascular disease.
    Aguilar B; Rojas JC; Collados MT
    J Thromb Thrombolysis; 2004 Oct; 18(2):75-87. PubMed ID: 15789174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine targeting of plasma proteins in hemodialysis patients.
    Jacobsen DW
    Kidney Int; 2006 Mar; 69(5):787-9. PubMed ID: 16518339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
    van Guldener C; Stehouwer CD
    Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study.
    Sundström J; Sullivan L; Selhub J; Benjamin EJ; D'Agostino RB; Jacques PF; Rosenberg IH; Levy D; Wilson PW; Vasan RS;
    Eur Heart J; 2004 Mar; 25(6):523-30. PubMed ID: 15039133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma total homocysteine: instigator or indicator of cardiovascular disease?
    Moat SJ
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):345-8. PubMed ID: 18583617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine and vitamins in cardiovascular disease.
    Jacobsen DW
    Clin Chem; 1998 Aug; 44(8 Pt 2):1833-43. PubMed ID: 9702993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where are we standing in homocysteine research?
    Herrmann W
    Clin Chem Lab Med; 2003 Nov; 41(11):1389-91. PubMed ID: 14656015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.